Creso Pharma (ASX:CPH) has just partnered with a Canadian company founded by two retired ice hockey players, agreeing to work together to sell each other’s hemp-based human health products.

ImpACTIVE Holdings has signed a non-binding letter of intent with Creso to distribute the company’s suite of CBD lozenges and ointments in the USA and Canada, while Creso will receive the rights to sell ImpACTIVE’s CBD inflammation-relieving stick roller in Switzerland and Europe.

The agreement builds on a second deal that Creso announced just last week – a partnership with CBD and plant-based remedies provider CERES Natural Remedies, for distribution of Creso’s animal health products in the USA, once the country legalises CBD products.

Creso, which can reach 2,100 points of sale in Switzerland through access to all key wholesalers in the country, says it expects to begin distribution of ImpACTIVE’s roll-on ProReLEAF stick there in April.

Initially Creso will target the growing sports and recreational market, the company said.

In turn, ImpACTIVE will distribute Creso’s cannaDOL revitalising gel and cannaQIX CBD lozenges through established sales channels, Creso said.

“We are very proud to enter the sports and recreational market with such a high-calibre partner as ImpActive,” says Creso commercial director Jorge Wernli

“This LOI (letter of intent) is important for Creso Pharma, as it further broadens our international footprint and provides another large market opportunity.

“We look forward to working with ImpACTIVE to ensure all products are well received in Europe and North America, and also leveraging their innovative product range to further add to the company’s growing sales profile.”

The launch of cannaDOl will be supported by Jenny Dietschweiler, a Swiss influencer and bodybuilder who is a two-time World Fitness Federation champion.

In a statement, Dietscheweiler said cannaDOL “brings substantial fast relief to joints and the muscles after intensive training. It enables faster high-perfomrance and re-achievement.”

“CannaDOL is really the way to enhance mobility.”

This article was developed in collaboration with Creso Pharma, a Stockhead advertiser at the time of publishing.

This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.